Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir Enema for HIV Prevention
NCT02750540Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tenofovir in human immunodeficiency virus infection (HIV), sponsored by Johns Hopkins University. Primary endpoints: Occurrence of adverse events Grade 2 or higher at 9 months, Area under the curve of tenofovir concentration matrix at 1 hr post dose and 9 more. Started Oct 2016; status: completed.
02
Drugs
tenofovir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02750540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02750540.